62/100B416.68
USD
0.61
(0.15%)
Market Closed
Last updated: · Delayed 15 min
BeiGene current ratioWhat is the current ratio? The current ratio is current assets divided by current liabilities: whether what a company will turn into cash within a year covers what it owes within a year.
BeiGene's current ratio is 3.55: current assets of 7.93B USD against current liabilities of 2.23B USD due within a year.
- Today
- 3.55
- Average, 5 years
- 3.12
- Low, 5 years
- 1.80
- High, 5 years
- 5.05
Current ratio = current assets ÷ current liabilities = 7.93B ÷ 2.23B = 3.55
Current ratio
Total current assets
Total current liabilities
Current assets over current liabilities at each quarter end: above 1, what falls due within a year is covered by what turns into cash within a year.
Current ratio by year and by quarter
| Fiscal year | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Today | 3.55 | 7.93B | 2.23B | |
| FY2025 | 31 Dec 2025 | 3.41 | 6.23B | 1.83B |
| FY2024 | 31 Dec 2024 | 1.80 | 3.99B | 2.21B |
| FY2023 | 31 Dec 2023 | 2.32 | 4.20B | 1.81B |
| FY2022 | 31 Dec 2022 | 3.55 | 5.21B | 1.47B |
| FY2021 | 31 Dec 2021 | 4.76 | 7.61B | 1.60B |
| FY2020 | 31 Dec 2020 | 4.61 | 4.96B | 1.08B |
| FY2019 | 31 Dec 2019 | 3.78 | 1.17B | 310.31M |
| FY2018 | 31 Dec 2018 | 7.89 | 1.94B | 246.45M |
| FY2017 | 31 Dec 2017 | 6.09 | 913.50M | 149.99M |
| FY2016 | 31 Dec 2016 | 10.68 | 374.40M | 35.06M |
| FY2015 | 31 Dec 2015 | 3.02 | 106.27M | 35.17M |
| FY2014 | 31 Dec 2014 | 3.53 | 47.19M | 13.37M |
| FY2013 | 31 Dec 2013 | 0.14 | 4.43M | 31.73M |
| Quarter | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 3.55 | 7.93B | 2.23B |
| Q2 FY2026 | 30 Jun 2026 | 3.40 | 7.22B | 2.12B |
| Q1 FY2026 | 31 Mar 2026 | 3.64 | 6.60B | 1.81B |
| Q4 FY2025 | 31 Dec 2025 | 3.41 | 6.23B | 1.83B |
| Q3 FY2025 | 30 Sept 2025 | 2.39 | 5.66B | 2.37B |
| Q2 FY2025 | 30 Jun 2025 | 1.95 | 4.31B | 2.21B |
| Q1 FY2025 | 31 Mar 2025 | 1.96 | 3.90B | 1.98B |
| Q4 FY2024 | 31 Dec 2024 | 1.80 | 3.99B | 2.21B |
| Q3 FY2024 | 30 Sept 2024 | 1.93 | 3.91B | 2.03B |
| Q2 FY2024 | 30 Jun 2024 | 1.98 | 3.84B | 1.94B |
| Q1 FY2024 | 31 Mar 2024 | 2.08 | 3.91B | 1.88B |
| Q4 FY2023 | 31 Dec 2023 | 2.32 | 4.20B | 1.81B |
| Q3 FY2023 | 30 Sept 2023 | 3.16 | 4.05B | 1.28B |
| Q2 FY2023 | 30 Jun 2023 | 3.13 | 4.40B | 1.41B |
| Q1 FY2023 | 31 Mar 2023 | 3.75 | 4.70B | 1.25B |
| Q4 FY2022 | 31 Dec 2022 | 3.55 | 5.21B | 1.47B |
| Q3 FY2022 | 30 Sept 2022 | 4.07 | 5.75B | 1.41B |
| Q2 FY2022 | 30 Jun 2022 | 4.54 | 6.35B | 1.40B |
| Q1 FY2022 | 31 Mar 2022 | 5.05 | 6.95B | 1.38B |
| Q4 FY2021 | 31 Dec 2021 | 4.76 | 7.61B | 1.60B |
| Q3 FY2021 | 30 Sept 2021 | 3.40 | 4.43B | 1.30B |
| Q2 FY2021 | 30 Jun 2021 | 3.86 | 4.80B | 1.24B |
| Q1 FY2021 | 31 Mar 2021 | 4.62 | 5.14B | 1.11B |
| Q4 FY2020 | 31 Dec 2020 | 4.61 | 4.96B | 1.08B |
| Q3 FY2020 | 30 Sept 2020 | 7.69 | 4.97B | 645.72M |
| Q2 FY2020 | 30 Jun 2020 | 6.15 | 3.39B | 551.20M |
| Q1 FY2020 | 31 Mar 2020 | 7.96 | 3.60B | 451.80M |
| Q4 FY2019 | 31 Dec 2019 | 3.78 | 1.17B | 310.31M |
| Q3 FY2019 | 30 Sept 2019 | 5.40 | 1.44B | 265.73M |
| Q2 FY2019 | 30 Jun 2019 | 6.46 | 1.76B | 271.68M |
| Q1 FY2019 | 31 Mar 2019 | 7.52 | 1.80B | 238.81M |
| Q4 FY2018 | 31 Dec 2018 | 7.89 | 1.94B | 246.45M |
| Q3 FY2018 | 30 Sept 2018 | 11.57 | 2.18B | 188.42M |
| Q2 FY2018 | 30 Jun 2018 | 8.14 | 1.52B | 186.44M |
| Q1 FY2018 | 31 Mar 2018 | 11.18 | 1.59B | 141.90M |
| Q4 FY2017 | 31 Dec 2017 | 6.09 | 913.50M | 149.99M |
| Q3 FY2017 | 30 Sept 2017 | 9.33 | 962.33M | 103.16M |
| Q2 FY2017 | 30 Jun 2017 | 8.38 | 418.69M | 49.95M |
| Q1 FY2017 | 31 Mar 2017 | 6.73 | 336.18M | 49.99M |
| Q4 FY2016 | 31 Dec 2016 | 10.68 | 374.40M | 35.06M |
| Q3 FY2016 | 30 Sept 2016 | 7.16 | 209.95M | 29.32M |
| Q2 FY2016 | 30 Jun 2016 | 11.37 | 232.75M | 20.47M |
| Q1 FY2016 | 31 Mar 2016 | 15.91 | 251.78M | 15.83M |
| Q4 FY2015 | 31 Dec 2015 | 3.02 | 106.27M | 35.17M |
| Q3 FY2015 | 30 Sept 2015 | 4.53 | 128.21M | 28.32M |
| Q2 FY2015 | 30 Jun 2015 | 4.99 | 130.20M | 26.11M |
| Q1 FY2015 | 31 Mar 2015 | — | 44.40M | 0.00 |
| Q4 FY2014 | 31 Dec 2014 | 3.53 | 47.19M | 13.37M |
| Q3 FY2014 | 30 Sept 2014 | — | — | — |
| Q2 FY2014 | 30 Jun 2014 | — | — | — |
| Q1 FY2014 | 31 Mar 2014 | — | — | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:Market cap,P/S ratio,ROE (return on equity),Debt to equity,All ratios
Common questions about BeiGene's current ratio
Source: Financial Modeling Prep